Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model
Böckelmann L, Freytag V, Ahlers A, Maar H, Gosau T, Baranowsky A, Schmitz R, Pantel K, Schumacher U, Haider M, Lange T
BONE. 2023;171:116741.

Rapid MRI Assessment of Long-Axis Strain to Indicate Systolic Dysfunction in Patients With Sickle Cell Disease
Grützediek K, Fischer R, Kurio G, Böckelmann L, Bleeke M, Hagar R, Tahir E, Grosse R, Weyhmiller M, Adam G, Bannas P, Schoennagel B
J MAGN RESON IMAGING. 2023;58(5):1499-1506.

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
Amsberg G, Zilles M, Mansour W, Gild P, Alsdorf W, Kaune M, Böckelmann L, Hauschild J, Krisp C, Rohlfing T, Saygi C, Alawi M, Zielinski A, Langebrake C, Su X, Perner S, Tilki D, Schluter H, Graefen M, Dyshlovoy S, Bokemeyer C
INT J MOL SCI. 2022;23(23):.

YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models
Böckelmann L, Felix T, Calabrò S, Schumacher U
CELL ONCOL. 2021;44(5):1183-1195.

Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src-family kinases as prognostic markers and potential targets
Bußmann L, Hoffer K, von Bargen C, Droste C, Lange T, Kemmling J, Schröder-Schwarz J, Vu A, Akingunsade L, Nollau P, Rangarajan S, de Wijn R, Oetting A, Müller C, Böckelmann L, Zech H, Berger J, Möckelmann N, Busch C, Böttcher A, Gatzemeier F, Klinghammer K, Simnica D, Binder M, Struve N, Rieckmann T, Schumacher U, Clauditz T, Betz C, Petersen C, Rothkamm K, Münscher A, Kriegs M
INT J CANCER. 2021;149(5):1166 - 1180.

Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets
Spethmann T, Böckelmann L, Labitzky V, Ahlers A, Schröder-Schwarz J, Bonk S, Simon R, Sauter G, Huland H, Kypta R, Schumacher U, Lange T
MOL ONCOL. 2021;15(7):1956-1969.

Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells
Böckelmann L, Starzonek C, Niehoff A, Karst U, Thomale J, Schlüter H, Bokemeyer C, Aigner A, Schumacher U
HISTOCHEM CELL BIOL. 2020;153(5):367-377.

Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker
Schröder J, Schumacher U, Böckelmann L
CANCERS. 2020;12(10):.

Targeting tumor interstitial fluid pressure: will it yield novel successful therapies for solid tumors?
Böckelmann L, Schumacher U
EXPERT OPIN THER TAR. 2019;23(12):1005-1014.

Letzte Aktualisierung aus dem FIS: 29.11.2024 - 23:34 Uhr